Article
Intracellular targeting with engineered proteins
2016-08-10
Abstract excerpt
If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated emphatically that proteins could be engineered, formulated, and employed for clinical advantage. Yet despite the succ...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0c11d74c-3ba7-5ca9-bfc4-519d868a4c06
- DOI
- 10.12688/f1000research.8915.1
